APA
TARA icon

American Portfolios Advisors’s Protara Therapeutics TARA Stock Holding History

American Portfolios Advisors’s Portfolio TARA Stock Details TARA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$296 Hold
100
– – ﹤0.01% 3439
2022
Q2 		$293 Hold
100
– – ﹤0.01% 3437
2022
Q1 		$511 Hold
100
– – ﹤0.01% 3464
2021
Q4 		$675 Hold
100
– – ﹤0.01% 3376
2021
Q3 		$692 Buy
+100
New +$780 ﹤0.01% 3356

Other funds holding TARA

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FAIM
Financial Advocates Investment Management Olympia, Washington $178M AUM 21.03% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

American Portfolios Advisors's TARA Position: Q3 2022 in Review

American Portfolios Advisors held its Protara Therapeutics (TARA) position steady in Q3 2022 at 100 shares worth $296. The position accounts for ﹤0.01% of the portfolio, ranked #3439.

American Portfolios Advisors first reported a position in TARA in Q3 2021 and has held it in 5 quarters since. The position peaked at $692 in Q3 2021. 31 funds tracked by Wall St. Rank hold TARA as of Q3 2022.

  • American Portfolios Advisors held 100 shares of Protara Therapeutics worth $296 as of Q3 2022.
  • American Portfolios Advisors left its Protara Therapeutics share count unchanged in Q3 2022.
  • Protara Therapeutics made up ﹤0.01% of American Portfolios Advisors's portfolio in Q3 2022, its #3439 holding.
  • American Portfolios Advisors first reported a position in Protara Therapeutics in Q3 2021 and has held it in 5 quarters since.
  • American Portfolios Advisors's Protara Therapeutics position peaked at $692 in Q3 2021.
  • 31 funds tracked by Wall St. Rank held Protara Therapeutics as of Q3 2022.

Based on American Portfolios Advisors's 13F filing for Q3 2022, filed 17 Mar 2023.